The Delhi High Court on Tuesday refused to grant Novo Nordisk an interim injunction against Dr. Reddy's Laboratories Ltd. and ...
Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar ...
India has the second-highest number of people with type 2 diabetes after China and rising obesity rates, making it a critical battleground for drugmakers ...
The Chosun Ilbo (English Edition) on MSN
Oral obesity drugs edge closer to FDA approval, South Korea preps
New obesity treatments, including ‘oral Mounjaro’ and ‘high-dose Wegovy,’ are scheduled to launch next year. The Danish ...
Danish drugmaker Novo Nordisk is set to launch its popular diabetes drug Ozempic in India this month. This move aims to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback